Biosensors are devices that can detect and measure the concentration of a specific analyte in a sample. Their development has saved millions of lives since the first commercial product was introduced in the 1970 (Clark et al.)
However, the enzymes that act as the central component of these devices have undergone little development since then. DirectSens was founded in 2013 to change that.
Enzymes are responsible for the main properties of the product, such as specificity and stability. Most biosensors use Oxidase or Dehydrogenase enzymes in combination with a two-step detection mechanism to generate a signal.
DirectSens has successfully pioneered the commercialization of 3rd generation biosensors that do not require mediators by using enzymes capable of Direct Electrode Transfer (DET).
Today, after 10 years in business, our portfolio includes enzymes useful for all common architectures of modern biosensor applications.
DirectSens uses the latest biotech engineering techniques to discover enzymes and tailor them to their intended use.
The ISO-certified facilities in Vienna, Austria, are capable of producing and supplying enzymes and sensors on a large scale.